Skip to content

Clinical trials

Phase 1 Breast Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1 Country / region: France Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20053
20063
20075
20091
20101
20123
20135
20144
20155
20165
20173
20183
20193
20205
20215
20224
20232
20247
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Active, not recruiting14
Terminated11
Recruiting10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals14
Eli Lilly and Company9
GlaxoSmithKline4
Hoffmann-La Roche4
AstraZeneca2
Boehringer Ingelheim2
Daiichi Sankyo2
European Organisation for Research and Treatment of Cancer - EORTC2
UNICANCER2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms73
Neoplasms15
Carcinoma, Non-Small-Cell Lung13
Colorectal Neoplasms10
Neoplasm Metastasis10
Endometrial Neoplasms9
Triple Negative Breast Neoplasms8
Lung Neoplasms7
Ovarian Neoplasms7
Stomach Neoplasms7

Trials

Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.